84 related articles for article (PubMed ID: 21323803)
21. Incidence of bleeding complications in pediatric patients with type 1 von Willebrand disease undergoing adenotonsillar procedures.
Witmer CM; Elden L; Butler RB; Manno CS; Raffini LJ
J Pediatr; 2009 Jul; 155(1):68-72. PubMed ID: 19394040
[TBL] [Abstract][Full Text] [Related]
22. [Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases].
Guermazi S; Conard J; Samama MM; Dellagi K
Pathol Biol (Paris); 2006 Apr; 54(3):159-65. PubMed ID: 16176858
[TBL] [Abstract][Full Text] [Related]
23. Major haemorrhage related to surgery in patients with type 1 and possible type 1 von Willebrand disease.
Woods AI; Blanco AN; Chuit R; Meschengieser SS; Kempfer AC; Farías CE; Lazzari MA
Thromb Haemost; 2008 Nov; 100(5):797-802. PubMed ID: 18989523
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease.
Pontara E; Gresele P; Cattini MG; Daidone V; Barbon G; Girolami A; Zanon E; Casonato A
Blood Coagul Fibrinolysis; 2014 Jun; 25(4):401-4. PubMed ID: 24418945
[TBL] [Abstract][Full Text] [Related]
25. Inherited disorders of platelet function and challenges to diagnosis of mucocutaneous bleeding.
Israels SJ; El-Ekiaby M; Quiroga T; Mezzano D
Haemophilia; 2010 Jul; 16 Suppl 5():152-9. PubMed ID: 20590875
[TBL] [Abstract][Full Text] [Related]
26. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
Castaman G; Tosetto A; Federici AB; Rodeghiero F
Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate) in patients with von Willebrand disorder requiring invasive or surgical procedures.
Shortt J; Dunkley S; Rickard K; Baker R; Street A
Haemophilia; 2007 Mar; 13(2):144-8. PubMed ID: 17286766
[TBL] [Abstract][Full Text] [Related]
28. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
29. Clinical diagnosis of von Willebrand disease.
Federici AB
Haemophilia; 2004 Oct; 10 Suppl 4():169-76. PubMed ID: 15479393
[TBL] [Abstract][Full Text] [Related]
30. Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia.
Flood VH; Johnson FL; Boshkov LK; Thomas GA; Nugent DJ; Bakke AC; Nicholson HS; Tilford D; Brown MP; Godder KT
Pediatr Blood Cancer; 2005 Dec; 45(7):971-5. PubMed ID: 15768382
[TBL] [Abstract][Full Text] [Related]
31. Coinheritance of severe von Willebrand disease with Glanzmann thrombasthenia.
Ahmad F; Kannan M; Kishor K; Saxena R
Clin Appl Thromb Hemost; 2010 Oct; 16(5):529-32. PubMed ID: 20147343
[TBL] [Abstract][Full Text] [Related]
32. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
[TBL] [Abstract][Full Text] [Related]
33. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.
Jilma B; Paulinska P; Jilma-Stohlawetz P; Gilbert JC; Hutabarat R; Knöbl P
Thromb Haemost; 2010 Sep; 104(3):563-70. PubMed ID: 20589313
[TBL] [Abstract][Full Text] [Related]
34. Von Willebrand's disease with thrombocytopenia, platelet function defect, and an abnormal Factor VIII molecule.
Arkel YS; Desposito F
Am J Pediatr Hematol Oncol; 1982; 4(3):249-57. PubMed ID: 6816083
[TBL] [Abstract][Full Text] [Related]
35. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
[TBL] [Abstract][Full Text] [Related]
36. [High-shear force-induced platelet aggregation in the screening and diagnosis of von Willebrand disease].
Schlammadinger A; Kerényi A; Muszbek L; Boda Z
Orv Hetil; 2000 Oct; 141(41):2245-50. PubMed ID: 11184249
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
Favaloro EJ
Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
[TBL] [Abstract][Full Text] [Related]
38. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
Favaloro EJ
Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
[TBL] [Abstract][Full Text] [Related]
39. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
40. Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses.
Choi S; Brull R
Anesth Analg; 2009 Aug; 109(2):648-60. PubMed ID: 19608843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
